The aim of the present paper is to evaluate the absorption of fumonisin B, and its principal metabolite, aminopentol on a human intestinal model, Caco-2 cells, cultured on semi-permeable inserts, that reproduces the two different intestinal compartments: luminal (apical) and serosal (basolateral) side. Following separate exposure in apical and in basolateral compartments, aminopentol passage through the cell layer (in particular from basolateral to apical direction) was shown, while it was not observed for the parent compound. The different aminopentol distribution between the two compartments of the culture system, and its variation in presence of verapamil or probenecid (P-gp and MRP inhibitors respectively), strongly suggests the involvement of P-glycoprotein in the influx/efflux mechanisms of aminopentol in the intestinal cells, reducing its oral bioavailability. (C) 2004 Elsevier Ltd. All rights reserved.

Absorption of Fumonisin B-1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein / I. De Angelis, G. Frigge', F. Raimondi, A. Stammati, F. Zucco, F. Caloni. - In: TOXICON. - ISSN 0041-0101. - 45:3(2005), pp. 285-291.

Absorption of Fumonisin B-1 and aminopentol on an in vitro model of intestinal epithelium; the role of P-glycoprotein

F. Caloni
2005

Abstract

The aim of the present paper is to evaluate the absorption of fumonisin B, and its principal metabolite, aminopentol on a human intestinal model, Caco-2 cells, cultured on semi-permeable inserts, that reproduces the two different intestinal compartments: luminal (apical) and serosal (basolateral) side. Following separate exposure in apical and in basolateral compartments, aminopentol passage through the cell layer (in particular from basolateral to apical direction) was shown, while it was not observed for the parent compound. The different aminopentol distribution between the two compartments of the culture system, and its variation in presence of verapamil or probenecid (P-gp and MRP inhibitors respectively), strongly suggests the involvement of P-glycoprotein in the influx/efflux mechanisms of aminopentol in the intestinal cells, reducing its oral bioavailability. (C) 2004 Elsevier Ltd. All rights reserved.
Aminopentol; Caco-2 cell line; Fumonisin B1; Intestinal absorption; P-gp
Settore VET/07 - Farmacologia e Tossicologia Veterinaria
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/7222
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 30
social impact